Q3 2024 EPS Estimates for Ayr Wellness Inc. Cut by Roth Capital (OTCMKTS:AYRWF)

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Equities researchers at Roth Capital lowered their Q3 2024 earnings per share estimates for Ayr Wellness in a research report issued on Wednesday, August 7th. Roth Capital analyst S. Fortune now anticipates that the company will earn ($0.31) per share for the quarter, down from their previous forecast of ($0.26). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.08) per share. Roth Capital also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.29) EPS, FY2024 earnings at ($1.22) EPS, Q1 2025 earnings at ($0.28) EPS, Q2 2025 earnings at ($0.27) EPS, Q3 2025 earnings at ($0.26) EPS, Q4 2025 earnings at ($0.26) EPS and FY2025 earnings at ($1.08) EPS.

Ayr Wellness (OTCMKTS:AYRWF) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.08). Ayr Wellness had a negative return on equity of 17.27% and a negative net margin of 39.55%. The company had revenue of $117.31 million for the quarter, compared to analyst estimates of $119.30 million.

Ayr Wellness Stock Performance

Ayr Wellness stock opened at $1.69 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.86 and a quick ratio of 0.87. The stock has a fifty day moving average price of $2.00 and a two-hundred day moving average price of $2.28. Ayr Wellness has a 52-week low of $0.79 and a 52-week high of $4.09. The firm has a market capitalization of $193.83 million, a P/E ratio of -0.80 and a beta of 2.09.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.